Current through Register Vol. 49, No. 18, September 16, 2024
(1) The
following words and terms, when used in this chapter, shall have the following
meanings.
(A) American Society of
Anesthesiologists (ASA) Classifications-A five- (5-) category classification
system used to assess a patient prior to sedation/anesthesia. Patients are
categorized into one (1) of the five (5) following classes:
1. Class I-There is no organic, physiologic,
biochemical, or psychiatric disturbance. The pathological process for which the
operation is to be performed is localized and is not a systemic disturbance.
The patient has no limits on his/her activity level and in general is to be
considered in good or excellent health;
2. Class II-Mild-to-moderate systemic
disturbance caused either by the condition to be treated surgically or by other
pathophysiological processes. The disease processes are stable or medically
controlled and they are not functionally limiting. Examples: tightly-controlled
insulin or non-insulin dependent diabetes; stable asthma; symptomatic
hypertension; controlled thyroid disease; smoker; obesity; or severe
anxiety;
3. Class III-Severe
systemic disturbance or disease from whatever cause, even though it may not be
possible to define the degree of disability with finality. Activity is
significantly limited by the disease, but is not totally incapacitating. The
patient may easily decompensate under stress. Examples: severe asthma; poorly
controlled diabetes mellitus; angina, especially if unstable or frequent; or
status post (S/P) myocardial infarction of cerebral vascular accident (CVA)
less than six (6) months ago;
4.
Class IV-Indicative of the patient with severe systemic disorder that is a
constant threat to life and not always correctable by the operative procedure.
Functionally incapacitating; a totally unstable patient who is in and out of
lethal states. Examples: unstable angina; congestive heart failure/chronic
obstructive pulmonary disease (CHF/COPD) requiring supplemental oxygen
(O2) or wheel-chair confinement, uncontrolled systemic
disease (diabetes mellitus); or symptomatic dysrhythmias; or
5. Class V-The moribund patient who has
little chance of survival but is submitted to operation in desperation. A
hospitalized patient of the expectant category.
(B) Analgesia-The diminution or elimination
of pain.
(C) Anesthesiologist-A
physician licensed by the Missouri State Board of Registration for the Healing
Arts in accordance with Chapter 334, RSMo, with privileges in general
anesthesia at an institution accredited by the Joint Commission on
Accreditation of Healthcare Organizations (JCAHO) or the American Osteopathic
Association (AOA).
(D) Certified
registered nurse anesthetist- A licensed registered professional nurse
recognized as an advanced practice nurse by the Missouri State Board of
Nursing, who is certified to administer anesthesia by a nationally recognized
certifying body approved by the Missouri State Board of Nursing in accordance
with Chapter 335, RSMo.
(E) Deep
sedation-A drug-induced depression of consciousness during which patients
cannot be easily aroused but respond purposefully following repeated or painful
stimulation. The ability to independently maintain ventilatory function may be
impaired. Patients may require assistance in maintaining a patent airway and
spontaneous ventilation may be inadequate. Cardiovascular function is usually
maintained.
(F) Deep
sedation/general anesthesia permit-A document issued by the Missouri Dental
Board to a dentist that allows the dentist to administer deep sedation/general
anesthesia.
(G) Deep
sedation/general anesthesia site certificate-A document issued by the Missouri
Dental Board to a specific dental office where deep sedation/general anesthesia
is administered.
(H) Dental
office-A facility where dentistry is practiced in accordance with the
provisions of section
332.071,
RSMo.
(I) Dentist-One who is
currently licensed to practice as a dentist in Missouri and is ultimately
responsible for the sedation procedure of a dental patient under his/her
care.
(J) Dentist-in-charge-A
dentist duly licensed by the board to practice at a facility in which sedation
anesthesia services are to be offered and who assumes the responsibility to
assure that the facility is properly equipped and the sedation team is properly
trained.
(K) Enteral minimal
sedation-A minimal level of sedation by a technique of administration in which
the drug is absorbed through the gastrointestinal tract or oral mucosa.
Enteral minimal sedation is not enteral moderate sedation,
parenteral moderate sedation, deep sedation, or general anesthesia.
(L) Enteral moderate sedation-A
minimal-to-moderate level of sedation by a technique of administration in which
the drug is absorbed through the gastrointestinal tract or oral mucosa (i.e.,
oral, rectal, or sublingual). Enteral moderate sedation is not parenteral
moderate sedation, deep sedation, or general anesthesia. Drugs used for enteral
moderate sedation shall not exceed one and one-half (1.5) times the maximum
recommended dose (MRD) for a period of twelve (12) hours before and after the
patient appointment (i.e., MRD for Triazolam is one-half milligram (0.5 mg).
One and one-half (1.5) times the MRD for Triazolam is three-fourths milligram
(0.75 mg) total dose for one (1) appointment).
(M) Enteral moderate sedation permit-A
document issued by the Missouri Dental Board to a dentist that allows the
dentist to administer enteral moderate sedation.
(N) Facility inspection-An inspection
confirming the adequacy of the dental office to provide enteral, parenteral, or
pediatric moderate sedation and/or deep sedation/general anesthesia by
consultants or other personnel appointed by the board to ensure public
safety.
(O) General anesthesia-A
drug-induced loss of consciousness during which patients are not arousable,
even by painful stimulation. The ability to independently maintain ventilatory
function is often impaired. Patients often require assistance in maintaining a
patent airway, and positive pressure ventilation may be required because of
depressed spontaneous ventilation or drug-induced depression of neuromuscular
function. Cardiovascular function may be impaired.
(P) Incremental dosing-Administration of
multiple doses of a drug until a desired effect is reached, but not to exceed
the maximum recommended dose (MRD).
(Q) Inhalation-A technique of administration
in which a gaseous or volatile agent is introduced into the lungs and whose
primary effect is due to absorption through the gas/blood interface.
(R) Local anesthesia-The elimination of
sensation, especially pain, in one (1) part of the body by the topical
application or regional injection of a drug. Note: Although the use of local
anesthetics is the foundation of pain control in dentistry and has a long
record of safety, dentists must be aware of the maximum, safe dosage limits for
each patient.
(S) Maximum
recommended dose (MRD)-Maximum United States Food and Drug Administration (FDA)
recommended dose of a drug, as printed in FDA-approved labeling for unmonitored
home use. Drugs used for enteral moderate sedation shall not exceed one and
one-half (1.5) times the maximum recommended dose (MRD) for a period of twelve
(12) hours before and after the patient appointment (i.e., MRD for Triazolam is
one-half milligram (0.5 mg). One and one-half (1.5) times the MRD for Triazolam
is three-fourths milligram (0.75 mg) total dose for one (1)
appointment).
(T) Minimal sedation
(Anxiolysis)-A minimally depressed level of consciousness produced by a
pharmacological method, which retains the patient's ability to independently
and continuously maintain an airway and respond normally to tactile stimulation
and verbal command. Although cognitive function and coordination may be
modestly impaired, ventilatory and cardiovascular functions are unaffected.
Note: In accord with this particular definition, the drug(s)
and/or techniques used should carry a margin of safety wide enough never to
render unintended loss of consciousness. Further, patients whose only response
is reflex withdrawal from repeated painful stimuli would not be considered to
be in a state of minimal sedation. When the intent is minimal sedation for
adults, the appropriate initial dosing of a single enteral drug is no more than
the maximum recommended dose (MRD) of a drug that can be prescribed for
unmonitored home use. The use of preoperative sedatives for children (aged
twelve (12) and under) except in extraordinary situations must be avoided due
to the risk of unobserved respiratory obstruction during transport by untrained
individuals. Children (aged twelve (12) and under) can become moderately
sedated despite the intended level of minimal sedation; should this occur, the
guidelines for moderate sedation apply. Nitrous oxide/oxygen may be used in
combination with a single enteral drug in minimal sedation. Nitrous
oxide/oxygen when used in combination with sedative agent(s) may produce
minimal, moderate, or deep sedation or general anesthesia.
(U) Moderate sedation-A drug induced
depression of consciousness during which patients respond purposefully to
verbal commands, either alone or accompanied by light tactile stimulation.
Generally, no interventions are required to maintain a patent airway, and
spontaneous ventilation is adequate. Cardiovascular function is usually
maintained. Note: In accord with this particular definition, the drugs and/or
techniques used should carry a margin of safety wide enough to render
unintended loss of consciousness unlikely. Repeated dosing of an agent before
the effects of previous dosing can be fully appreciated may result in a greater
alteration of the state of consciousness than is the intent of the dentist.
Further, a patient whose only response is reflex withdrawal from a painful
stimulus is not considered to be in a state of moderate sedation. The following
definitions apply to the administration of moderate or greater sedation:
1. Titration-Administration of incremental
doses of a drug until a desired effect is reached. Knowledge of each drug's
time of onset, peak response, and duration of action is essential to avoid over
sedation. Although the concept of titration of a drug to effect is critical for
patient safety, when the intent is moderate sedation, the dentist must know
whether the previous dose has taken full effect before administering an
additional drug increment; and
2.
Supplemental dosing-During moderate sedation, supplemental dosing is a single
additional dose of the initial dose of the initial drug that may be necessary
for prolonged procedures. The supplemental dose should not exceed one-half
(0.5) of the initial dose and should not be administered until the dentist has
determined the clinical half-life of the initial dosing has passed. The total
aggregate dose must not exceed one and one-half (1.5) times the MRD on the day
of treatment.
(V)
Moderate sedation site certificate-a document issued by the Missouri Dental
Board to a specific dental office where enteral or parenteral moderate sedation
is administered.
(W) On-site
evaluation-A performance evaluation of the competency of the sedation team by
consultants appointed by the board to ensure public safety.
(X) Operating dentist-The Missouri licensed
dentist who is performing the dental procedure on a sedated patient. The
operating dentist is ultimately responsible for all patient care, including
sedation, regardless of whether the care is rendered personally by the dentist,
or by another qualified sedation provider.
(Y) Parenteral moderate sedation-A level of
minimal to moderate sedation by a technique of administration in which the drug
bypasses the gastrointestinal tract, i.e., routes of administration:
intravenous (I.V.), intramuscular (I.M.), intranasal (I.N.), subcutaneous
(S.C.), submucosal (S.M.), or intraosseous (I.O.). Parenteral moderate sedation
is not deep sedation or general anesthesia.
(Z) Parenteral moderate sedation permit- A
document issued by the Missouri Dental Board to a dentist that allows the
dentist to administer parenteral moderate sedation.
(AA) Pediatric moderate sedation permit-
A document issued by the Missouri Dental Board to a dentist
to administer moderate sedation to pediatric patients as defined in subsection
(1)(BB) of this rule.
(BB)
Pediatric patient-A patient aged twelve (12) or under. The use of preoperative
sedatives for children (aged twelve (12) and under) except in extraordinary
situations must be avoided due to the risk of unobserved respiratory
obstruction during transport by untrained individuals. Children (aged twelve
(12) and under) can become moderately sedated despite the intended level of
minimal sedation; should this occur, the guidelines for moderate sedation
apply.
(CC) Qualified sedation
provider-Any of the following who have satisfied the provisions of this rule:
1. A currently licensed dentist in Missouri
with a valid permit to administer enter-al, parenteral, or pediatric moderate
sedation;
2. A currently licensed
anesthesiologist; or
3. A currently
licensed certified registered nurse anesthetist.
(DD) Sedation team-Those individuals,
including the qualified sedation provider and operating dentist, qualified
pursuant to
20 CSR
2110-4.030(7)(B) involved with the
treatment and/or monitoring of a sedation patient.
(EE) Time-oriented anesthesia record-
Documentation at appropriate time intervals of drugs, doses, and physiologic
data obtained during patient monitoring.
(FF) Transdermal-A technique of
administration in which the drug is administered by patch or iontophoresis
through skin.
(GG) Transmucosal-A
technique of administration in which the drug is administered across mucosa
such as intranasal, sub-lingual, or rectal.
*Original authority: 332.031, RSMo 1969, amended 1981,
1993, 1995; 332.071, RSMo 1969, amended 1976, 1995, 2003, 2004, 2006; and
332.361, RSMo 1969, amended 1981.